Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH

Austria Muellner Hauptstrasse 48, 5020 Salzburg, Austria

About the sponsor

The EB Haus Study Centre in Salzburg is involved in clinical research focused on recessive dystrophic epidermolysis bullosa, a severe inherited condition marked by fragile skin and chronic wound burden.

  • Recessive dystrophic epidermolysis bullosa
  • Skin fragility disorders
  • Chronic wound complications

This area reflects a clinical interest in the dermatologic and tissue-healing challenges associated with rare genetic blistering diseases.

About Specializations

Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH runs clinical trials in conditions such as Epidermolysis bullosa, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Epidermolysis bullosa

Not recruiting

Study on Rigosertib Sodium for Patients with Recessive Dystrophic Epidermolysis Bullosa and Advanced Squamous Cell Carcinoma

InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rigosertib Sodium
  • Sponsor:Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.